Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Current challenges in the development of vaccines for pneumonic plague

Stephen T Smiley1

  • 1Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, NY 12983, USA. ssmiley@trudeauinstitute.org

Expert Review of Vaccines
|March 8, 2008
PubMed

Insights

Pneumonic plague, caused by Yersinia pestis, is a severe threat due to antibiotic resistance and lack of vaccines. Future vaccines should aim to stimulate both humoral and cellular immunity for better protection.

Area of Science:

  • Microbiology and Immunology
  • Vaccinology
  • Biodefense

Background:

  • Pneumonic plague, caused by Yersinia pestis, is a highly virulent and rapidly progressing disease.
  • The emergence of extensively antibiotic-resistant Y. pestis strains and the absence of a safe, effective pneumonic plague vaccine pose significant biothreat concerns.
  • Yersinia pestis is a potential bioweapon agent, necessitating urgent development of countermeasures.

Purpose of the Study:

  • To review the historical development and current status of plague vaccine research.
  • To advocate for a specific immunological approach for future pneumonic plague vaccine development.

Main Methods:

  • Literature review of plague vaccine research history and current state.
  • Analysis of immunological requirements for effective pneumonic plague prevention.

Main Results:

  • Plague vaccine research has a long history, but a safe and effective vaccine for pneumonic plague remains elusive.
  • Current research faces challenges due to Y. pestis virulence and antibiotic resistance.

Conclusions:

  • A critical need exists for a safe and effective pneumonic plague vaccine.
  • Future vaccine development strategies should prioritize the induction of both humoral and cellular immunity to combat Yersinia pestis effectively.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Concept Videos

Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...